Trials / Conditions / Disseminated Intravascular Coagulation

Disseminated Intravascular Coagulation

23 registered clinical trials studyying Disseminated Intravascular Coagulation — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Role of Fibrinolytic Activity in Neoplastic Pathologies Complicated by Coagulopathy NCT07234630	University Hospital, Strasbourg, France	—
Active Not Recruiting	An Observational Study in the United States to Learn How Venous Thromboembolism, Disseminated Intravascular Co NCT06765681	Bayer	—
Not Yet Recruiting	Predictive Value of Scoring System in Neonates with Disseminated Intravascular Coagulation NCT06626880	Assiut University	—
Recruiting	Longitudinal Cohort of Thrombosis and Hemostasis Diseases NCT06727669	Peking University People's Hospital	—
Recruiting	Disseminated Intravascular Coagulation (DIC) Score and Organ Dysfunction in Septic Shock Patients NCT06363149	Sanjay Gandhi Postgraduate Institute of Medical Sciences	—
Completed	An Observational Study to Learn About the Occurrence of Disseminated Intravascular Coagulation Among Adults Wi NCT06373159	Bayer	—
Unknown	The Proactive Diagnostic Value of Hemostatic Biomarkers in Disseminated Intravascular Coagulation NCT05995093	Qilu Hospital of Shandong University	—
Completed	Standardized Olive Leaf Capsules; as a Co-therapy in the Treatment of COVID-19 Patients NCT04873349	Shimaa M. Abdelgawad	N/A
Completed	Infusional Fluorouracil and Weekly Docetaxel for Gastric Cancer With Bone Marrow Involvement and DIC NCT04547153	Sixth Affiliated Hospital, Sun Yat-sen University	Phase 2
Completed	Study Assessing Efficacy of Plasmatherapy in Septic Shock-induced Coagulopathy: Feasibility Study NCT04580563	University Hospital, Strasbourg, France	N/A
Completed	Coagulation Changes Associated With COVID-19 Infection NCT04460664	HemoSonics LLC	—
Withdrawn	The LEAD COVID-19 Trial: Low-risk, Early Aspirin and Vitamin D to Reduce COVID-19 Hospitalizations NCT04363840	Louisiana State University Health Sciences Center in New Orleans	Phase 2
Completed	Analysis of the Coagulopathy Developed by COVID-19 Infected Patients NCT04356950	Centre Hospitalier Universitaire de Nīmes	—
Completed	Thrombomodulin-modified Thrombin Generation Assay (TGA-TM) in Patients With Critical Infections NCT04356144	Medical University of Vienna	—
Completed	Blood Management During ECMO for Cardiac Support NCT03714048	St Vincent's Hospital, Sydney	—
Completed	PLatelets Acetyl-CoA Carboxylase Phosphorylation State in SEPtic Shock NCT04107402	Cliniques universitaires Saint-Luc- Université Catholique de Louvain	N/A
Unknown	Efficacy and Safety of Unfractionated Heparin on Severe Sepsis With Suspected Disseminated Intravascular Coagu NCT02654561	China Medical University, China	Phase 3
Unknown	International Prospective Registry of Disseminated Intravascular Coagulation NCT03577015	Marcella Muller	—
Completed	Platelet Reactivity in Septic Shock NCT03716310	Università degli Studi di Ferrara	—
Completed	Clinical Pharmacokinetics Study of ART-123 in Disseminated Intravascular Coagulation (DIC) Subjects With Renal NCT01704001	Asahi Kasei Therapeutics Corporation	Phase 4
Terminated	Recombinant Human Antithrombin (ATryn®) in the Treatment of Patients With DIC Associated With Severe Sepsis NCT00506519	LEO Pharma	Phase 2
Completed	Safety and Efficacy of ART-123 in Subjects With Sepsis and Disseminated Intravascular Coagulation NCT00487656	Artisan Pharma, Inc.	Phase 2
Terminated	Thrombin Generation and Thromboelastography in Non-overt DIC NCT00299949	The University of Texas Health Science Center, Houston	—